Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Niagara Mohawk Power $1.25 billion senior notes offering
The investment-grade notes are due 2030 and 2055
Valterra Platinum demerger from Anglo American
We advised Valterra Platinum on the U.S. law aspects of the transaction
Honda $3 billion senior notes offering
The investment-grade notes are due 2028, 2030 and 2035
JBS $3.5 billion senior notes offerings and tender offer
The notes are due 2036, 2056 and 2066
Banco Santander €1.5 billion cash tender offer for AT1 notes
We advised Banco Santander on its tender offer for contingent convertible perpetual notes
Amrize $3.4 billion notes offering
The investment-grade notes are due 2027, 2028, 2030 and 2035
Amrize $1.8 billion exchange offers for Holcim bonds
The exchange offers were conducted in connection with Holcim’s spinoff of Amrize
xAI $3 billion senior secured notes offering
The senior secured notes are due 2030
Globe Life $500 million P-Cap transaction
The securities are intended to serve as a source of contingent liquidity
Medtide HK$411.2 million IPO
We advised Medtide on its IPO and HKEX listing